The Economist 20260620 Biology's plague journal Summary

Generated by Codex with GPT 5.6 Sol XHigh

This summary covers The Economist’s June 20th, 2026 Science & technology article listed as Ancient plagues and published under the headline Biology's plague journal.

Plague left more than mass graves and historical fear. It also left genetic evidence inside human teeth. The article explains how scientists are using that ancient DNA to reconstruct the disease’s evolution, identify outbreaks that written history never recorded and challenge the idea that plague needed crowded cities to become catastrophic.

Continue ...

The Economist 20260620 A player or a spectator Summary

Generated by Codex with GPT 5.6 Sol XHigh

This summary covers The Economist’s June 20th, 2026 Britain article listed as The AI opportunity and published under the headline A player or a spectator?.

Britain has many of the ingredients for a successful artificial-intelligence industry: strong research, experienced founders, abundant venture capital and a government more willing than the European Union to let firms experiment. Yet the article’s central warning is that potential is not the same as power. Unless Britain turns its scientific strengths into infrastructure, companies and widespread adoption, it may watch the AI revolution from the sidelines.

Continue ...

The Economist 20260620 The new-seekers Summary

Generated by Codex with GPT 5.6 Sol XHigh

This summary covers The Economist’s June 20th, 2026 Finance & economics article listed in the contents as AI-pilled economists and published under the headline The new-seekers.

Artificial intelligence may reshape work, productivity and economic growth, yet many academic economists have been slow to study it. The article argues that the centre of AI economics is consequently moving away from universities and toward government agencies, think-tanks and the AI labs themselves. That shift gives researchers better data and closer contact with the technology, but it also risks putting important public questions inside institutions with commercial interests and limited incentives to share what they learn.

Continue ...

The Economist 20260620 Token reckoning Summary

Generated by Codex with GPT-5

This summary covers The Economist’s June 20th, 2026 Business article listed in the contents as Big bills for tokenmaxxing and published under the headline Token reckoning.

Artificial intelligence is creating a new corporate headache: the more useful AI agents become, the harder their costs are to control. These systems do more than answer a prompt. They reason through several steps, call tools and sometimes create other agents, consuming large numbers of tokens - the units of text that AI companies commonly use for billing. As agents spread across the many software products used by a large company, small charges can compound into an enormous bill.

Continue ...

The Economist 20260620 Has one of cancer's master switches been found Summary

Generated by Codex with GPT-5

This summary covers The Economist’s June 20th, 2026 Science & technology / Well Informed article listed in the contents as A cancer breakthrough and published under the headline Has one of cancer's master switches been found?.

Pancreatic cancer is one of medicine’s hardest targets: it is aggressive, often detected late and usually resists immunotherapy. The article argues that a new drug, daraxonrasib, matters because it has produced a rare and meaningful gain against that disease while also pointing toward a broader class of cancer treatments.

Continue ...

The Economist 20260620 Wrong prescription Summary

Generated by Codex with GPT-5

This summary covers The Economist’s June 20th, 2026 Leaders article listed in the contents under Chinese biotech and published under the headline Wrong prescription.

The article argues that America is in danger of mistaking medical innovation for another battlefield in its technology contest with China. Chinese biotechnology has moved from imitation to genuine discovery, and American drug companies are increasingly licensing Chinese-developed molecules. Some politicians now want to treat that trend as a national-security threat, extending investment restrictions to biotech deals and even asking the Food and Drug Administration to disregard Chinese clinical-trial data.

Continue ...

The Economist 20260620 How Europe must respond to America's AI warning shot Summary

Generated by Codex with GPT-5

This summary covers The Economist’s June 20th, 2026 By Invitation article by Judith Dada, listed in the contents as Judith Dada on the stakes for Europe in AI and published under the headline How Europe must respond to America's AI warning shot.

The essay argues that Donald Trump’s order forcing Anthropic to block non-Americans from its newest frontier models should jolt Europe out of complacency. For the first time, a government had compelled the withdrawal of publicly released advanced AI from foreign users. Whether the ban lasts is less important than what it revealed: Europe depends on American firms, American infrastructure and American political tolerance for access to the most powerful AI systems.

Continue ...

The Economist 20260620 A bouncer gone berserk Summary

Generated by Codex with GPT-5

This summary covers The Economist’s June 20th, 2026 Briefing article listed in the contents under Access to AI and published under the headline A bouncer gone berserk.

A Ban That Shows Power And Weakness

The article argues that Donald Trump’s order forcing Anthropic to block foreigners from its most advanced Fable 5 and Mythos 5 models is less a coherent AI strategy than a dramatic proof of American control. Washington may have been trying to punish Anthropic after security concerns about its models, but the result was much larger: allies, companies and governments discovered that access to frontier AI could vanish overnight by political decree.

Continue ...

The Economist 20260620 A test of faith Summary

Generated by Codex with GPT-5

This summary covers The Economist’s June 20th, 2026 Briefing article listed in the contents under Anthropic and published under the headline A test of faith.

The article presents Anthropic not just as another artificial-intelligence startup, but as a company whose moral self-image has become part of its power. Founded by defectors from OpenAI who believed frontier AI needed stricter safeguards, Anthropic built its identity around safety, caution and a quasi-missionary belief that artificial general intelligence could reshape civilization. That stance once made it look like the pious sibling in the AI race. Now that its models are commercially valuable and strategically sensitive, the same posture has put it in direct conflict with the American state.

Continue ...

The Economist 20260620 America's AI power grab Summary

Generated by Codex with GPT-5

This summary covers The Economist’s June 20th, 2026 Leaders article listed in the contents under Artificial intelligence and published under the headline America's AI power grab.

The article argues that America’s most important new geopolitical asset may not be a carrier group, a reserve currency or a trade route. It may be the ability to decide who can use the most capable frontier AI models. When the Trump administration ordered Anthropic to block non-Americans from its latest Fable and Mythos models, the immediate trigger was a reported jailbreak. The broader message was larger: Washington can turn access to the world’s leading AI systems into an instrument of state power.

Continue ...